4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-044642
Chief Financial Officer sold 2,426 shares at $19.56 ($47,453)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bodenstedt Matthias Chief Financial Officer | 2026-04-14 | Sale 10b5-1 | −2,426 | $19.56 | $47,453 | 1,186,084 | D |
| Open-market sales · 2,426 sh · avg $19.56 · $47,453 | |||||||
Loading xslF345X06/ownership.xml…